ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences.
Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myeloproliferative neoplasms (MPN) are a group of rare clonal disorders of hematopoietic progenitor cells associated with disease- related symptoms, thrombotic events, and risk of transformation to acute myeloid leukemia (Tefferi, 2021). Their relative rarity and complexity of care led to the establishment of the MPN program at the Princess Margaret (PM) Cancer Centre, Toronto, Canada. The MPN program utilizes a shared-care model wherein partnering with local hematologists (shared-care partners) ensures that patients have access to a MPN specialist while continuing to receive care close to home. The clinical nurse specialist (CNS) role was implemented in late 2016 to support not only the shared-care model, but also to triage new patient referrals, and support consultation and follow-up. Although the CNS role has been part of the healthcare system since the 1940s, the role and its impact remain unclear at times to the inter-disciplinary team. This paper describes the process and results in evaluating the CNS role's impact in the MPN program through using a multi-method approach. In this Part II of a series, the focus is on discussing the team and patient care experience with having a CNS as part of the care team.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.